CYP2C8 and CYP2C9 polymorphisms in relation to tumour characteristics and early breast cancer related events among 652 breast cancer patients

BACKGROUND: CYP2C8/9 polymorphisms may influence breast cancer-free survival after diagnosis due to their role in the metabolism of tamoxifen, paclitaxel, and other chemotherapy. cytochrome P450 (CYP)2C8/9 metabolise arachidonic acid to epoxyeicosatrienoic acids, which enhance migration and invasion...

Descripción completa

Detalles Bibliográficos
Autores principales: Jernström, H, Bågeman, E, Rose, C, Jönsson, P-E, Ingvar, C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2788256/
https://www.ncbi.nlm.nih.gov/pubmed/19935798
http://dx.doi.org/10.1038/sj.bjc.6605428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2788256/
https://www.ncbi.nlm.nih.gov/pubmed/19935798
http://dx.doi.org/10.1038/sj.bjc.6605428

Ejemplares similares